Retinal and choroidal vascular density alterations in patients with schizophrenia: assessment via optical coherence tomography angiography

• by Jun Liu, Guangyuan Wang, Hui Zhang, Suqi Song, Kai Zhang, Ruimei Ni, Le Ren, Yayun Xu, Dachuan Zhang, Yong Wang, Zhengxuan Jiang

• January 31, 2026

Transdiagnostic Patterns of Grip Strength in Schizophrenia, Current Depression, and Remitted Depression

• by Sofie von Känel, Anastasia Pavlidou, Niluja Nadesalingam, Victoria Chapellier, Melanie G. Nuoffer, Lydia Maderthaner, Alexandra Kyrou, Alexios Malifatouratzis, Florian Wüthrich, Stephanie Lefebvre, Victor Pokorny, Zachary Anderson, Stewart A. Shankman, Vijay A. Mittal, Sebastian Walther

• May 1, 2026

Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia

• by Florian J. Raabe, David Popovic, Clara Vetter, Laura E. Fischer, Genc Hasanaj, Berkhan Karslı, Tim J. Schäfer, Valeria Almeida, Alessia Atella, Miriam Gagliardi, Emanuel Boudriot, Vladislav Yakimov, Lucia Trastulla, Tengjia Jiang, Clara Weyer, Lukas Roell, Joanna Moussiopoulou, Lenka Krčmář, Sabrina Galinski, Irina Papazova, Oliver Pogarell, Alkomiet Hasan, Eva C. Schulte, Andrea Schmitt, Nikolaos Koutsouleris, Anna Levina, Elias Wagner, Moritz J. Rossner, Sergi Papiol, Peter Falkai, Daniel Keeser, Michael J. Ziller, CDP Working Group, Stephanie Behrens, Man-Hsin Chang, Valéria de Almeida, Sylvia de Jonge, Fanny Dengl, Lina Dürrwald, Nadja Gabellini, Vanessa Gabriel, Thomas Geyer, Katharina Hanken, Alexandra Hisch, Georgios Ioannou, Marcus Ising, Iris Jäger, Marcel Kallweit, Temmuz Karali, Susanne Karch, Christoph Kern, Nicole L. Klimas, Maxim Korman, Lenka Krcmar, Verena Meisinger, Julian Melcher, Matin Mortazavi, Karin Neumeier, Frank Padberg, Boris Papazov, Pauline Pingen, Siegfried G. Priglinger, Philipp Sämann, Susanne Schmölz, Enrico Schulz, Benedikt Schworm, Sophie Seeburger, Sven Wichert, Peter Zill

• May 1, 2026

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min